Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet

por Sun, Lei, Yagoda, Sergey, Du, Yangchun, von Moltke, Lisa
Publicado 2019

Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate

por Sun, Lei, Yagoda, Sergey, Yao, Baiyun, Graham, Christine, von Moltke, Lisa
Publicado 2019

M105. ACTIGRAPHIC MONITORING OF SLEEP-WAKE CYCLE IN SCHIZOPHRENIA OUTPATIENTS RECEIVING A LONG-ACTING INJECTABLE ANTIPSYCHOTIC: FEASIBILITY AND INITIAL RESULTS FROM A PROSPECTIVE R...

por Yagoda, Sergey, Wolz, Robin, Weiden, Peter J, Claxton, Amy, Yao, Baiyun, Du, Yangchun
Publicado 2020

Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outco...

por Nasrallah, Henry A., Weiden, Peter J., Walling, David P., Du, Yangchun, Yao, Baiyun, Yagoda, Sergey, Claxton, Amy
Publicado 2021

Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study

por Correll, Christoph U, Stein, Evan, Graham, Christine, DiPetrillo, Lauren, Akerman, Sarah, Stanford, Arielle D, Jiang, Ying, Yagoda, Sergey, McDonnell, David, Hopkinson, Craig
Publicado 2022